SanBio Co Stock

SanBio Co OCF/Debt

The Operating Cash Flow to Debt Ratio of SanBio Co (4592.T) as of Aug 19, 2026 is -907.58 %. In the previous year, Operating Cash Flow to Debt Ratio was -716.64 % — a change of 26.64% (lower).

OCF/Debt

-907.58 %

YoY

26.64%

Last updated:

Operating Cash Flow to Debt Ratio of SanBio Co is 2026 -907.58 % . Operating Cash Flow to Debt Ratio of SanBio Co was 2025 -716.64 % . It decreases by 26.64% lower compared to the previous year.
Access this data via the Eulerpool API

SanBio Co Stock analysis

What does SanBio Co do? SanBio Co Ltd is a leading bio-pharmaceutical company focused on the development of products for the treatment of serious neurological diseases. The company was founded in Japan in 2000 and has since become a multinational company with offices in the USA and Europe. Answer: SanBio Co Ltd is a bio-pharmaceutical company that specializes in developing products for the treatment of serious neurological diseases. It was founded in Japan in 2000 and has expanded to become a multinational company with offices in the USA and Europe. SanBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SanBio Co stock

Operating Cash Flow to Debt Ratio of SanBio Co is -907.58 % in 2026.

Operating Cash Flow to Debt Ratio of SanBio Co changed from -716.64 % to -907.58 %, representing a 26.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio SanBio Co since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's SanBio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — SanBio Co

All Key Metrics — SanBio Co